Next Generation Immunotherapies

In R&D by Freya SmaleLeave a Comment

Peter Keller, Vice President Business Development, Selecta Biosciences joined us at the World Vaccine Congress Lyon 2012 to present on Synthetic Vaccine Particle technology. This …